New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2021 - Sanofi and Regeneron announced the FDA approval of Libtayo (cemiplimab-rwlc).
Download PDF
Return to publications
